Adimab LLC. Expands Executive Team with Addition of Philip T. Chase as General Counsel
1/5/2012 7:42:39 AM
LEBANON, N.H.--(BUSINESS WIRE)--Adimab, LLC, a leader in the discovery of fully human antibodies, today announced that Philip T. Chase has joined the company as General Counsel. Mr. Chase comes to Adimab with extensive legal and deal-making experience in the biotechnology industry. Most recently, Mr. Chase served as the General Counsel at Alnylam Pharmaceuticals where he oversaw all legal functions during a time when Alnylam executed and managed numerous significant partnerships, including large technology collaborations with Roche and Takeda.